Research and Development

The Research and Development team at Allorion Therapeutics is responsible for advancing small molecule therapies targeting cancer and autoimmune diseases. This includes translational biology, drug metabolism and pharmacokinetics (DMPK), clinical pharmacology, informatics, and medicinal chemistry. The team conducts in-depth research, preclinical studies, and early-stage clinical trials to identify and optimize promising therapeutic candidates.